A word from the founder
Watch Video
A word from the founder
Watch Video
A word from the founder
Watch Video
A word from the founder
Watch Video
Fighting
Cancer early!
Innovative Genomic approach
Early detection is key to increasing cure rates and reducing mortality.
Early detection is key to increasing cure rates and reducing mortality.
Alercell is committed to revolutionizing early detection through advanced DNA sequencing techniques. By identifying cancer at its earliest stages, Alercell aims to assist patients in achieving better outcomes, potentially even preventing the progression of the disease entirely.
Alercell is committed to revolutionizing early detection through advanced DNA sequencing techniques. By identifying cancer at its earliest stages, Alercell aims to assist patients in achieving better outcomes, potentially even preventing the progression of the disease entirely.
Alercell is committed to revolutionizing early detection through advanced DNA sequencing techniques. By identifying cancer at its earliest stages, Alercell aims to assist patients in achieving better outcomes, potentially even preventing the progression of the disease entirely.
Service
Our Diagnostics
Our Diagnostics
Our approach enables a deeper understanding of how genetic
alterations contribute to diseases like cancer
Our approach enables a deeper understanding of how genetic alterations contribute to diseases like cancer
01
Lena S1 Test
Lena S1 Test
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
DNA Methylation in Early Lung Cancer Detection
DNA Methylation in Early Lung Cancer Detection
DNA Methylation in Early Lung Cancer Detection
DNA Methylation in Early Lung Cancer Detection
Limitations of Traditional Methods and Lena S1's Solution
Limitations of Traditional Methods and Lena S1's Solution
Limitations of Traditional Methods and Lena S1's Solution
Limitations of Traditional Methods and Lena S1's Solution
02
LENA Q51®
LENA Q51®
Innovative approach to leukemia diagnostics by targeting gene mutations, clonogenic gene rearrangements, and abnormal gene expression.
Fusion Genes as Key Biomarkers in Leukemia
Fusion Genes as Key Biomarkers in Leukemia
Fusion Genes as Key Biomarkers in Leukemia
Fusion Genes as Key Biomarkers in Leukemia
LENA Q51's Breakthrough
LENA Q51's Breakthrough
LENA Q51's Breakthrough
LENA Q51's Breakthrough
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy